Increased hepatic expression of Gpr119 and Cd68, but not Cnr1 (Supplementary Fig. 13a, b) was also detected in mice with CL-HFS-induced NASH and human patients with obesity and NASH. Here, GPR119 is linked to metabolic dysfunction-associated steatohepatitis.